Stephen de Souza, MD
Retina Specialist · Phoenix, AZNPI 1548232820
Payments from drug & device makers
Across 706 payments — averaging $1348.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ocular Therapeutix, Inc.$474K
- Boehringer Ingelheim$377K
- US Retina LLC$83K
- Boehringer Ingelheim International GmbH$5K
- Alimera Sciences, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $8K from 21 others
Across 1 payment — averaging $10,717 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ocular Therapeutix, Inc. | 105 | $474,258 |
| Boehringer Ingelheim | 66 | $377,301 |
| US Retina LLC | 14 | $82,547 |
| Boehringer Ingelheim International GmbH | 53 | $5,484 |
| Alimera Sciences, Inc. | 23 | $2,788 |
| Regeneron Healthcare Solutions, Inc. | 89 | $2,388 |
| Bausch & Lomb Americas Inc. | 26 | $1,485 |
| Genentech USA, Inc. | 144 | $1,386 |
| AbbVie(2 entities) | 77 | $1,147 |
| Eyepoint US, Inc. | 23 | $619 |
| Astellas Pharma US Inc | 19 | $503 |
| Alcon | 11 | $479 |
| Genentech, Inc. | 4 | $314 |
| Novartis | 10 | $282 |
| Dutch Ophthalmic, USA | 6 | $260 |
| Regeneron | 3 | $214 |
| Apellis Pharmaceuticals, Inc. | 9 | $182 |
| Harrow Eye, LLC | 6 | $142 |
| ANI Pharmaceuticals, Inc. | 7 | $138 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $121 |
| Coherus Oncology, Inc. | 3 | $72 |
| Mallinckrodt Enterprises LLC | 1 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| Rhythm Pharmaceuticals, Inc. | 2 | $33 |
| Neurotech Pharmaceuticals, Inc. | 1 | $25 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Halozyme Inc | 1 | $15 |
How this compares
$952,267 in reported general payments places this provider in the 85th percentile of 30 retina specialist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Phoenix
- Jordan GraffPhoenix$4.4M
- Henry KwongPhoenix$3.4M
- Alan GordonPhoenix$1.2M
- Rahul ReddyPhoenix$581K
- Benjamin BakallPhoenix$533K
- Suhail AlamPhoenix$476K
- Jack SipperleyPhoenix$409K
- Joseph BryanPhoenix$199K
- Jaime GaitanPhoenix$187K
- Rima PatelPhoenix$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.